|
HS Code |
498700 |
| name | Yohimbine HCl |
| chemical_formula | C21H27ClN2O3 |
| CAS_number | 65-19-0 |
| molecular_weight | 390.9 g/mol |
| appearance | White to off-white crystalline powder |
| solubility | Soluble in water |
| purity | Typically ≥98% |
| storage_temperature | Store at 2-8°C |
| usage | Dietary supplement, fat loss, and aphrodisiac |
| route_of_administration | Oral |
As an accredited Yohimbine HCl factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tamper-evident HDPE bottle labeled "Yohimbine HCl, 25g," featuring hazard symbols and handling instructions in black print. |
| Shipping | Yohimbine HCl is typically shipped in tightly sealed, chemical-resistant containers to ensure stability and prevent contamination. Packages must comply with relevant regulations, including labeling and documentation for safe transport. The chemical should be kept away from moisture and direct sunlight during shipping, and may require temperature control to preserve its integrity. |
| Storage | Yohimbine HCl should be stored in a tightly sealed container, protected from light and moisture, at room temperature (15–30°C or 59–86°F). Store the chemical in a well-ventilated, dry area away from incompatible substances and sources of ignition. Ensure proper labeling and restrict access to authorized personnel. Follow all local regulations and safety guidelines for hazardous chemicals. |
Applications of Yohimbine HCl in Industrial ManufacturingYohimbine hydrochloride, produced under stringent GMP protocols, is valued for its regulated incorporation into several industrial verticals. Our material supports customers’ finished product quality through consistent analytical control and process integration. Below, we present targeted downstream sectors, detailing regulatory alignment, formulation practices, manufacturing flow, and final product endpoints for true-to-market B2B industrial users. 1. Pharmaceutical Active Pharmaceutical Ingredient (API) ProductionAPI manufacturers utilize yohimbine hydrochloride as a critical component in prescription and over-the-counter medications for specific vasodilatory and sexual health therapies. Facilities strictly monitor raw material input for identity, purity, and trace-level contaminants, while batch traceability and validated cleaning cycles govern GMP lines. Different dosage forms—such as oral tablets and injectables—require process adjustments to match pharmacopoeial release standards and dosage uniformity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Therapeutics ProductionYohimbine hydrochloride is essential in the synthesis of veterinary reversal agents, particularly in products used to counteract xylazine-induced sedation in animals. Production must adhere to animal health GMP requirements, and manufacturers rigorously validate excipient compatibility and dose uniformity within veterinary product lines, considering species-specific dosing regimens and veterinarian-administered formats. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Analytical Reference Standards PreparationProducers of pharmaceutical testing laboratories and research institutions require highly purified yohimbine hydrochloride as analytical reference material for qualitative and quantitative chromatographic calibration. Strict batch-to-batch consistency, exact content uniformity, and traceability to international reference standards underpin this segment, with documentation and accreditation as critical deliverables for downstream users. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Nutraceutical Capsule and Tablet Manufacturing (Regulated Jurisdictions Only)Select international markets allow regulated use of yohimbine hydrochloride in food supplement manufacture, subject to strict limits. Manufacturers must validate identity, residual solvents, and heavy metals rigorously, with batch controls anchored in the relevant jurisdiction’s permissible daily intake regulations. Application focuses on encapsulation or tablet blending processes for standardized finished dosage forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Yohimbine HCl prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer with decades of hands-on experience, turning bulk plant extracts into well-defined compounds is more than a technical achievement—it reflects a responsibility to deliver quality with each batch. Yohimbine hydrochloride (Yohimbine HCl) reflects this approach in full. We manufacture Yohimbine HCl under strict controls, beginning with botanical selection and extraction. Raw material inconsistency runs rampant in the market. Our operation starts with verified Pausinystalia yohimbe bark, processed and purified through a line of reactors and filtration columns developed to minimize contaminants and standardize output.
Purity, assay, and structural identity receive our attention well before packaging or shipment. Batch records, full chromatographic profiles, and confirmation by nuclear magnetic resonance guarantee product consistency. No substitute for quality assurance exists here. This attention pays off in reliability—a necessary factor when raw Yohimbine HCl can be subject to adulteration or variable potency elsewhere.
Our current Yohimbine HCl output achieves purity levels of no less than 98% by HPLC, with typical batches exceeding 99%. Loss on drying stays tightly controlled, and residual solvents, heavy metals, and related alkaloids remain below the limits set by major regional and global pharmacopoeias. The finished product forms a white or nearly white crystalline powder that meets precise solubility, melting point, and moisture criteria. Particle size is regulated throughout the production process to meet customer demands for different downstream uses, whether for research, finished pharmaceuticals, nutraceutical ingredients, or further synthesis. Certificate of analysis and traceability documentation ship with every lot, issued by our in-house analytical labs.
Actual numbers matter. This not only enables our customers to plan for formulation and scale-up, but also removes the guesswork from pilot work or quality control investigations. Investment in analytical equipment—like LC-MS/MS and advanced IR spectrometry—has allowed us to tighten acceptance criteria and reject unacceptable lots before release. That is one major way a manufacturing origin affects a customer’s operating reality: the supply chain becomes cleaner, recordkeeping more trustworthy, and surprises in lab or plant environments drop to a minimum.
Yohimbine in its hydrochloride form holds an enduring presence across many domains. Pharmaceutical developers value its selectivity for alpha-2 adrenergic receptors, making it a longstanding ingredient in medications for sexual health and peripheral vasodilation. In lower doses and carefully controlled conditions, research teams continue to explore Yohimbine’s effect on central nervous system response and metabolic pathways, shining a light on its role in fat metabolism, anxiety, and cognition.
Manufacturers in the supplement market use Yohimbine HCl as an ingredient in energy and weight management formulations, leveraging both consumer interest and pharmacological evidence. Each of these applications places a premium on verifiable quality and supply chain accountability. From a chemical supplier’s viewpoint, the focus remains on delivering material that reliably meets regulatory standards and delivers the performance demanded by formulation scientists, researchers, and quality managers. Consistency is everything; failed release testing or out-of-spec batches can halt projects or damage brand trust, particularly in highly regulated spaces like pharmaceuticals or NSF-certified nutrition.
It’s tempting to treat all Yohimbine HCl as interchangeable, but direct practical experience as a producer paints a different picture. Crude yohimbe bark extracts found on the market may cite alkaloid percentages without substantiating purity or confirming absence of unwanted analogs. The entire class of yohimbe-derived alkaloids is structurally diverse, with only Yohimbine itself (in hydrochloride salt form) meeting most pharmacopoeial standards for API use.
Extracts can feature multiple alkaloids—ajmalicine, corynanthine, and others—potentially confounding both research reproducibility and clinical safety. The isolation and purification route for Yohimbine HCl, compared to basic bark powder or semi-purified extracts, eliminates many of these unwanted compounds. Quality-verified Yohimbine HCl brings laboratory confidence on identity, which matters in clinical trials, product registration, and international trade where documentation is scrutinized.
Speculative versions of Yohimbine hydrochloride often trace back to trading operations that repackage materials, sometimes without origin details or meaningful documentation. We contrast that with in-house synthesis or isolation: you receive batch-by-batch continuity, supply chain accountability, and a technical team able to answer troubleshooting or formulation questions. Our production lines undergo regular audits and improvement rounds to align with evolving standards. Customers developing regulated medical products or large-scale nutritional formulas benefit here. For them, a direct source means regulatory compliance and predictable project timelines, not to mention safety from recalls and border detentions.
Some new customers compare Yohimbine HCl directly with alternative botanical or synthetic compounds—rauwolscine, synephrine, or chemically related molecules. Having worked with a range of these actives, our technical opinion is guided by side-by-side process evaluation and commercial feedback. Yohimbine HCl’s binding affinity and selectivity in adrenergic modulation remain unique within the class; no off-the-shelf replacement delivers identical clinical effects or regulatory support. From a process point of view, the synthesis or isolation of Yohimbine HCl tends to be more complex and costly, raising the bar for smaller operations or those prone to shortcuts.
Customers searching for raw powder alternatives, including yohimbe bark powder or “whole” extracts, discover limits in standardization. Lot-to-lot variation, undocumented origins, and lack of analytical support all pose business risks. Finished dosage forms relying on crude yohimbe powder face high hurdles in quality control and stability testing. We see this regularly: clients who tried “bargain” sources contact us when they encounter inconsistent performance or compliance audits. Yohimbine HCl from a manufacturer with traceable records closes these gaps.
For research users exploring other adrenergic actives, clarity on molecular identity and batch purity remains paramount. Complexity in botanical extracts dilutes experimental power. Every major published study referencing Yohimbine HCl as the active relies on full structural confirmation—nothing less will suffice, especially if the end goal involves clinical translation or regulatory filing.
No Yohimbine HCl program succeeds without engagement with regulatory agencies. Our teams work to harmonize documentation with pharmacopeial or market-specific requirements, including certificates recognized in North America, the EU, and key Asian markets. This mindset influences the entire production process, from incoming raw material intake through process controls, cleaning validation, and documentation.
Contaminants receive particular scrutiny: residual solvent traces, heavy metals, and microbial content hit predefined thresholds based on end-market requirements. Data tie each shipping lot back to its batch record, so recall or audit requests are straightforward to resolve. Investing in updated record management and electronic releases supports both traceability and real-time communication with regulatory inspections. Technical support includes not only regular COAs but detailed process protocols and supporting data available as needed. These practices emerge not from abstract ideals, but from direct feedback cycles with pharmaceutical clients, supplement formulators, and regulatory reviewers who have little patience for incomplete or ambiguous documentation.
Not every supplier can speak directly from experience troubleshooting variations in alkaloid extraction yields, solvent recovery, or endpoint purification. We see customers face issues with caking, color development, or loss of activity due to poor storage or improper mixing. Our technical staff maintains open lines with customer facilities, sometimes even adapting process parameters for large-scale formulations to account for plant-specific climate, humidity, or handling infrastructure.
Direct experience with formulation teams uncovered the importance of correct excipient selection, dosage preparation, and stability testing. For Yohimbine HCl destined for tablets or capsules, we provide guidance on interaction with fillers, preservation of alkaloid stability, and mitigation of oxidation or moisture uptake. Real-world feedback has prompted us to upgrade packaging for better moisture protection and longer shelf stability, especially for customers in tropical climates. Those small improvements come from responding to data from the field, not just the demands of internal protocols.
Being a manufacturer means we take personal responsibility for the supply chain, not just managing suppliers but driving verification processes from start to finish. Our raw yohimbe bark suppliers undergo screening, geographic verification, and regular audits not limited to contract reviews—we visit plantation sites and insist on sustainable harvesting practices, in part to ensure the long-term viability of the resource.
Raw material markets for yohimbe bark can fluctuate in both price and legal status. As regulation tightens around CITES-listed species, we monitor compliance up and down the chain. All batches leaving our facility possess origin documentation and phytosanitary records as required by importing jurisdictions. This might not matter to a trader or reseller, but for anyone needing clear passage through customs, evidence of sustainable sourcing, and fast answers during audits, it pays major dividends.
Change is constant in chemical manufacturing. Increasing regulatory pressure, shifting public perception of “natural” ingredients, and evolving analytical tools bring new challenges. We adopt adaptive process controls, update hazardous materials management systems, and maintain process safety mapping for every reactor and storage vessel. Training programs for line operators and lab technicians ensure not only compliance, but technical mastery—something hard to fake in audit or crisis settings. Each upgrade or process change follows risk-based validation, documented in accessible records for customer review on request.
Reducing waste and environmental impact also factors into process decisions. Recycled solvent capture, energy-efficient drying, and minimized water use have all reduced our operational footprint. Communicating these sustainability achievements directly to customers allows product users to highlight their own commitments, building trust up the value chain. Sustainable manufacturing practices aren’t buzzwords here—they affect sourcing options, long-term pricing stability, and regulatory standing. Customers increasingly ask for documentation of sustainable practices before new contracts are awarded, particularly for corporate buyers or organizations under external scrutiny.
Beyond physical shipment, access to technical support draws a major line between manufacturing sources and the rest. A trained team able to answer real questions—solubility profiles, ideal storage conditions, recommended formulation strategies, and regulatory documentation requests—saves months of trial and error for downstream users. Bi-directional feedback improves not just the compound, but its adaptability to customer requirements as markets shift. Our teams maintain regular communication with both large and small groups, including updates on analytical trends and regulatory shifts affecting alkaloid ingredients worldwide.
We collaborate frequently with research institutions and formulation specialists to troubleshoot unique project needs or to adapt the bulk compound for improved end-user experience. Practical suggestions earned in the field—better flowability, improved stability under stress, custom particle sizing—arise directly from customer challenges rather than hypothetical product design. As regulatory frameworks evolve, particularly regarding controlled substances or botanically derived actives, our engagement with compliance experts keeps both our operation and our clients one step ahead.
Our approach to manufacturing Yohimbine HCl centers on full-chain visibility, technical rigor, and solution-based support. The end product differs from others through documented origin, high-grade purification, and reliable technical partnership across continents and industries. Key clients across the globe value that stability, both for regulated pharmaceuticals and competitive consumer products. Manufacturers can offer more than just bulk chemicals; through continued investment in quality, transparency, and process adaptability, we help customers de-risk their operations while delivering a compound that meets the market’s toughest performance and compliance expectations.
Every new partnership reminds us that reliable manufacturing translates into improved end-user trust, smoother project delivery, and better outcomes in research and final-use applications. This feedback loop between plant floor, laboratory, and customer outcome ensures that improvement is never just a manufacturing slogan, but a foundation for real-world advantage. By staying invested in every stage, from bark source to final shipment, we continue to raise the standard for Yohimbine HCl supply in a market where details truly matter.